S&P 500
(0.14%) 5 467.91 points
Dow Jones
(0.03%) 39 132 points
Nasdaq
(0.61%) 17 840 points
Oil
(2.34%) $83.45
Gas
(-4.69%) $2.48
Gold
(-0.01%) $2 339.30
Silver
(0.07%) $29.58
Platinum
(-2.47%) $989.10
USD/EUR
(-0.13%) $0.932
USD/NOK
(-0.04%) $10.67
USD/GBP
(0.06%) $0.791
USD/RUB
(1.05%) $86.62

Sanntidsoppdatering for Atrion Corp [ATRI]

Børs: NASDAQ Sektor: Healthcare Industri: Medical Instruments & Supplies
Sist oppdatert1 jul 2024 @ 19:24

-0.03% $ 452.31

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 19:24):
Our systems believe the stock currently is undervalued by 0.32% compare to its pairs and should correct upwards.

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally...

Stats
Dagens volum 19 808
Gjennomsnittsvolum 33 240
Markedsverdi 796.04M
EPS $1.590 ( Q1 | 2024-05-10 )
Neste inntjeningsdato ( $0 ) 2024-08-06
Last Dividend $2.20 ( 2024-06-14 )
Next Dividend $0 ( N/A )
P/E 42.59
(Sector) 42.63
(Industry) 0
ATR14 $0.249 (0.05%)
AKYA -6.84%
ANGO -5.37%
APR 0.00%
ATRC -1.80%
ATRI -0.03%
ATRS 0.18%
AVGR -8.33%
AZTA -3.14%
BLFS -3.87%
EKSO -0.95%
FEMY 2.63%
GMVD 1.38%
HBIO -1.05%
HOLX -0.37%
ICUI -3.20%
IIN 0.12%
ISRG -2.38%
KRMD -11.70%
LMAT -3.09%
LMNX 0.00%
MASI -7.03%
MBOT -0.99%
MHUA 16.85%
MMSI -0.66%
NEPH -0.71%
NSTG -37.43%
NVCR 2.69%
NXGL -1.00%
OSUR -0.94%
PDEX -6.82%
PLSE -3.31%
POAI -0.96%
QDEL -3.73%
RGEN -2.13%
SDC -53.45%
SMTI -3.38%
STAA -0.40%
STSS -1.29%
UTMD 0.15%
XRAY -1.22%
ZTEK 0.00%
Insider Trading
Date Person Action Amount type
2024-05-21 Stupp John P Jr Buy 311 Deferred Stock Unit
2024-05-21 Bankes Jeannette Buy 311 Deferred Stock Unit
2024-05-21 Athey Preston G Buy 311 Deferred Stock Unit
2024-05-21 Spaulding Ronald Nicholas Buy 311 Deferred Stock Unit
2024-05-20 Battat David A Buy 847 restricted stock units
INSIDER POWER
50.90
Last 93 transactions
Buy: 21 075 | Sell: 27 609
Korrelasjon (AI algo v.1.1b): Undervalued: 0.32% $454.45 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.06 (neutral)
Kort: -0.29 (neutral)
Signal:(66.244) Neutral

Atrion Corp Korrelasjon

10 Mest positive korrelasjoner
OZEM1
STRL0.92
HDL0.909
GRID0.903
ITRI0.9
HUMA0.9
AIRR0.893
FRPT0.889
IINN0.888
EBIZ0.886
10 Mest negative korrelasjoner
FTRE-0.891
SOFO-0.881
FIVN-0.865
PEV-0.864
NAAS-0.855
ETAO-0.855
GDEN-0.854
ACCD-0.852
SBFG-0.851
AEI-0.849

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Atrion Corp Korrelasjon - Valuta/Råvare

The country flag -0.13
( neutral )
The country flag -0.47
( neutral )
The country flag -0.06
( neutral )
The country flag -0.29
( neutral )
The country flag -0.22
( neutral )
The country flag -0.17
( neutral )

Atrion Corp Økonomi

Annual 2023
Omsetning: $169.33M
Bruttogevinst: $62.39M (36.84 %)
EPS: $11.02
FY 2023
Omsetning: $169.33M
Bruttogevinst: $62.39M (36.84 %)
EPS: $11.02
FY 2022
Omsetning: $183.51M
Bruttogevinst: $75.90M (41.36 %)
EPS: $19.59
FY 2021
Omsetning: $165.01M
Bruttogevinst: $69.37M (42.04 %)
EPS: $18.00

Financial Reports:

No articles found.

Atrion Corp Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$2.15
(N/A)
$2.15
(N/A)
$2.15
(N/A)
$2.15
(N/A)
$2.20
(N/A)
$2.20
(N/A)
$2.20
(N/A)
$2.20
(N/A)
$0
(N/A)
$0
(N/A)

Atrion Corp Dividend Information - Dividend King

Dividend Sustainability Score: 9.54 - good (95.42%) | Divividend Growth Potential Score: 5.64 - Stable (12.85%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.183 1990-02-12
Last Dividend $2.20 2024-06-14
Next Dividend $0 N/A
Payout Date 2024-06-28
Next Payout Date N/A
# dividends 119 --
Total Paid Out $99.01 --
Avg. Dividend % Per Year 1.23% --
Score 5.27 --
Div. Sustainability Score 9.54
Div.Growth Potential Score 5.64
Div. Directional Score 7.59 --
Next Divdend (Est)
(2024-07-25)
$2.23 Estimate 72.54 %
Dividend Stability
0.97 Excellent
Dividend Score
5.27
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1990 $0.732 9.87%
1991 $0.732 7.71%
1992 $0.783 7.12%
1993 $0.800 5.27%
1994 $0.800 5.78%
1995 $0.800 7.27%
1996 $0.800 5.60%
1997 $0.600 3.87%
1998 $0 0.00%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0.240 1.07%
2004 $0.520 1.14%
2005 $0.620 1.33%
2006 $0.740 1.09%
2007 $0.880 1.12%
2008 $1.080 0.87%
2009 $1.320 1.36%
2010 $10.56 6.78%
2011 $1.820 0.97%
2012 $12.10 5.03%
2013 $2.40 1.19%
2014 $2.78 0.96%
2015 $3.30 0.97%
2016 $3.90 1.04%
2017 $4.50 0.90%
2018 $5.10 0.82%
2019 $5.80 0.79%
2020 $6.60 0.89%
2021 $7.40 1.13%
2022 $8.20 1.17%
2023 $8.70 1.53%
2024 $4.40 1.12%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
14 Jun 2024 $2.20 21 May 2024 14 Jun 2024 28 Jun 2024
14 Mar 2024 $2.20 27 Feb 2024 15 Mar 2024 29 Mar 2024
30 Nov 2023 $2.20 13 Nov 2023 01 Dec 2023 15 Dec 2023
14 Sep 2023 $2.20 22 Aug 2023 15 Sep 2023 29 Sep 2023
14 Jun 2023 $2.15 23 May 2023 15 Jun 2023 30 Jun 2023
14 Mar 2023 $2.15 27 Feb 2023 15 Mar 2023 31 Mar 2023
30 Nov 2022 $2.15 14 Nov 2022 01 Dec 2022 15 Dec 2022
14 Sep 2022 $2.15 22 Aug 2022 15 Sep 2022 30 Sep 2022
14 Jun 2022 $1.950 24 May 2022 15 Jun 2022 30 Jun 2022
14 Mar 2022 $1.950 25 Feb 2022 15 Mar 2022 31 Mar 2022
30 Nov 2021 $1.950 12 Nov 2021 01 Dec 2021 15 Dec 2021
14 Sep 2021 $1.950 30 Aug 2021 15 Sep 2021 30 Sep 2021
14 Jun 2021 $1.750 21 May 2021 15 Jun 2021 30 Jun 2021
12 Mar 2021 $1.750 26 Feb 2021 15 Mar 2021 31 Mar 2021
30 Nov 2020 $1.750 13 Nov 2020 01 Dec 2020 15 Dec 2020
14 Sep 2020 $1.750 20 Aug 2020 15 Sep 2020 30 Sep 2020
12 Jun 2020 $1.550 21 May 2020 15 Jun 2020 30 Jun 2020
13 Mar 2020 $1.550 26 Feb 2020 16 Mar 2020 31 Mar 2020
29 Nov 2019 $1.550 12 Nov 2019 02 Dec 2019 16 Dec 2019
13 Sep 2019 $1.550 19 Aug 2019 16 Sep 2019 30 Sep 2019

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Diamond 2024-09-16 Monthly 14 15.03% 9.60
DMLP Dividend Diamond 2024-04-26 Quarterly 22 10.71% 9.35
OXSQ Dividend Diamond 2024-09-16 Monthly 21 12.73% 9.02
ARLP Dividend Royal 2024-05-07 Quarterly 26 9.67% 8.87
PNNT Dividend Royal 2024-06-14 Monthly 18 9.49% 8.82
MFIC Dividend Royal 2024-06-11 Quarterly 21 10.89% 8.79
SPOK Dividend Royal 2024-05-23 Quarterly 20 8.73% 8.72
PSEC Dividend Royal 2024-06-25 Monthly 21 9.03% 8.65
SBLK Dividend Royal 2024-06-06 Quarterly 17 13.10% 8.63
GBDC Dividend Royal 2024-11-29 Bi-Monthly 15 8.53% 8.62

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1061.5007.8810.00[0 - 0.5]
returnOnAssetsTTM0.07241.2007.599.11[0 - 0.3]
returnOnEquityTTM0.07751.500-0.250-0.375[0.1 - 1]
payoutRatioTTM0.823-1.0001.773-1.773[0 - 1]
currentRatioTTM9.180.80010.008.00[1 - 3]
quickRatioTTM2.860.80010.008.00[0.8 - 2.5]
cashRatioTTM0.5821.5007.8810.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM142.621.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM15.442.004.859.71[0 - 30]
freeCashFlowPerShareTTM5.242.007.3810.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.3381.0007.717.71[0.2 - 0.8]
operatingProfitMarginTTM0.1201.0009.599.59[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.6830.8008.787.02[0.5 - 2]
Total Score9.54

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM42.541.0005.800[1 - 100]
returnOnEquityTTM0.07752.50-0.161-0.375[0.1 - 1.5]
freeCashFlowPerShareTTM5.242.008.2510.00[0 - 30]
dividendYielPercentageTTM1.9451.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM15.442.004.859.71[0 - 30]
payoutRatioTTM0.8231.5001.773-1.773[0 - 1]
pegRatioTTM16.261.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1541.0008.650[0.1 - 0.5]
Total Score5.64

Atrion Corp Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Atrion Corp

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 2.4082539081573 seconds
Number of API calls: 3
Number of DB calls: 9